Author | Charles G. Drake, MD, PhD | OncLive

Author | Charles G. Drake, MD, PhD

Articles

Dr. Drake on the Role of Cytoreductive Nephrectomy in RCC

August 07, 2018

Video

Charles G. Drake, MD, PhD, director of Genitourinary Oncology, NewYork-Presbyterian/Columbia University Medical Center and co-director of Columbia’s Cancer Immunotherapy Programs, discusses the role of cytoreductive nephrectomy in the treatment of patients with renal cell carcinoma.

Dr. Drake Discusses the Results of the CARMENA Study in RCC

August 02, 2018

Video

Charles G. Drake, MD, PhD, director of Genitourinary Oncology, NewYork-Presbyterian/Columbia University Medical Center and co-director of Columbia’s Cancer Immunotherapy Programs, discusses the results of the CARMENA study in patients with metastatic renal cell carcinoma.

Dr. Drake Discusses the CARMENA Trial in Metastatic RCC

June 14, 2018

Video

Charles G. Drake, MD, PhD, director of Genitourinary Oncology, NewYork-Presbyterian/Columbia University Medical Center and co-director of Columbia’s Cancer Immunotherapy Programs, discusses the CARMENA trial in metastatic renal cell carcinoma (mRCC).

Dr. Drake Discusses Immunotherapy Agents in Bladder Cancer

April 28, 2017

Video

Charles G. Drake, MD, PhD, director of Genitourinary Oncology, NewYork-Presbyterian/Columbia University Medical Center and co-director of Columbia’s Cancer Immunotherapy Programs, discusses immunotherapy agents in bladder cancer.

x